Annual Drug Patent Expirations for CAMPTOSAR
Camptosar is a drug marketed by Pfizer Inc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug and one Paragraph IV challenge.
The generic ingredient in CAMPTOSAR is irinotecan hydrochloride. One supplier is listed for this compound. Additional details are available on the irinotecan hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
